Not Rated
|
Fund Size
(0.53% of Investment in Category)
|
Expense Ratio
(0.89% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 04-Nov-25 | 9891.00 | -1.09% | - | -0.36% | 189/231 |
| 1 Month | 10-Oct-25 | 9882.60 | -1.17% | - | 0.94% | 212/227 |
| 3 Month | 11-Aug-25 | 10144.60 | 1.45% | - | 4.69% | 207/224 |
| 6 Month | 09-May-25 | 10867.40 | 8.67% | - | 11.50% | 155/213 |
| YTD | 01-Jan-25 | 9811.50 | -1.89% | - | 4.88% | 161/201 |
| 1 Year | 11-Nov-24 | 10280.10 | 2.80% | 2.80% | 5.15% | 121/187 |
| 2 Year | 10-Nov-23 | 15008.50 | 50.09% | 22.44% | 20.43% | 49/141 |
| 3 Year | 11-Nov-22 | 18383.80 | 83.84% | 22.48% | 20.12% | 35/117 |
| 5 Year | 11-Nov-20 | 24265.40 | 142.65% | 19.39% | 22.30% | 63/93 |
| Since Inception | 02-Jul-18 | 43088.00 | 330.88% | 21.93% | 14.09% | 27/199 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 11-Nov-24 | 12000 | 12497.47 | 4.15 % | 7.73 % |
| 2 Year | 10-Nov-23 | 24000 | 27321.06 | 13.84 % | 12.97 % |
| 3 Year | 11-Nov-22 | 36000 | 48857.44 | 35.72 % | 20.83 % |
| 5 Year | 11-Nov-20 | 60000 | 95177.66 | 58.63 % | 18.49 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| # Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 3388.9 | 12.01% | 0.00% | 12.5% (Apr 2025) | 10.74% (Jul 2025) | 20.04 L | 0.00 |
| # Divis Laboratories Ltd. | Pharmaceuticals | 2504.4 | 8.88% | 0.00% | 8.53% (Jun 2025) | 4.96% (Oct 2024) | 3.72 L | -5.00 k |
| # Glenmark Pharmaceuticals Ltd. | Pharmaceuticals | 1808.1 | 6.41% | 0.00% | 7.24% (Jul 2025) | 5.22% (Apr 2025) | 9.56 L | -0.30 L |
| # Apollo Hospitals Enterprises Ltd. | Hospital | 1751.6 | 6.21% | 0.00% | 6.37% (Jun 2025) | 4.82% (Dec 2024) | 2.28 L | -4.00 k |
| # Cipla Ltd. | Pharmaceuticals | 1528.4 | 5.42% | 0.00% | 7.6% (Feb 2025) | 6.03% (Sep 2025) | 10.18 L | -0.90 L |
| # Lupin Ltd. | Pharmaceuticals | 1431.7 | 5.07% | 0.00% | 6.37% (Apr 2025) | 4.94% (Jul 2025) | 7.29 L | 0.00 |
| # Fortis Healthcare Ltd. | Hospital | 1220.6 | 4.33% | 0.00% | 4.19% (Sep 2025) | 2.12% (Jan 2025) | 11.93 L | 0.00 |
| # Aurobindo Pharma Ltd. | Pharmaceuticals | 1153.1 | 4.09% | 0.00% | 8.05% (Oct 2024) | 4.33% (Sep 2025) | 10.12 L | -0.90 L |
| # Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 1133.5 | 4.02% | 0.00% | 6.38% (Dec 2024) | 4.13% (Jul 2025) | 9.46 L | 0.00 |
| # Krishna Institute of Medical Sciences Ltd. | Hospital | 1064 | 3.77% | 0.00% | 4.32% (Nov 2024) | 3.57% (Feb 2025) | 14.76 L | 0.00 |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 0.78% |
| MF Units | MF Units | 0.01% |
| Net Receivables | Net Receivables | -0.10% |
Ratios calculated on daily returns for last 3 years (Updated as on 31st October, 2025)
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Nippon India Taiwan Equity Fund - Direct Plan - Growth | NA | 421.51 | 1.03 | 16.25 | 53.74 | 44.73 | 38.77 |
| Aditya Birla Sun Life International Equity Fund - Direct Plan - Growth | NA | 273.51 | 2.49 | 4.87 | 19.26 | 30.41 | 16.95 |
| Quant BFSI Fund - Direct Plan - Growth | NA | 680.73 | 4.48 | 8.62 | 20.77 | 25.20 | 0.00 |
| HDFC Transportation and Logistics Fund - Direct Plan - Growth | NA | 1733.63 | 1.11 | 12.15 | 24.63 | 24.32 | 0.00 |
| Franklin Asian Equity Fund - Direct - Growth | NA | 297.12 | 2.35 | 11.50 | 20.87 | 24.06 | 15.08 |
| Nippon India Japan Equity Fund - Direct Plan - Growth | NA | 292.35 | 2.43 | 4.70 | 13.50 | 20.74 | 18.45 |
| ITI Banking and Financial Services Fund - Direct Plan - Growth | NA | 333.18 | 4.18 | 8.60 | 8.34 | 20.47 | 15.36 |
| DSP Banking & Financial Services Fund - Direct Plan - Growth | NA | 1518.73 | 3.01 | 7.70 | 8.60 | 20.08 | 0.00 |
| HDFC Defence Fund - Direct Plan - Growth | NA | 7556.72 | 0.39 | 8.71 | 16.54 | 19.88 | 0.00 |
| SBI Banking & Financial Services Fund - Direct Plan - Growth | NA | 9273.44 | 3.08 | 6.60 | 10.74 | 19.34 | 20.51 |
Out of 51 mutual fund schemes offered by this AMC, 3 is/are ranked 5 * , 4 is/are ranked 4 * , 4 is/are ranked 3 * , 4 is/are ranked 2 * , and 36 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Mirae Asset Large Cap Fund - Direct Plan - Growth | 3 | 41087.55 | 1.85 | 4.90 | 9.79 | 8.11 | 13.85 |
| Mirae Asset Large & Midcap Fund - Direct Plan - Growth | 3 | 40821.90 | 2.14 | 6.86 | 14.16 | 8.40 | 18.11 |
| Mirae Asset ELSS Tax Saver Fund - Direct Plan - Growth | 4 | 25910.64 | 1.87 | 5.99 | 12.58 | 8.92 | 18.18 |
| Mirae Asset Midcap Fund - Direct Plan - Growth | 3 | 17194.25 | 2.43 | 7.87 | 19.89 | 10.00 | 21.80 |
| Mirae Asset Liquid Fund - Direct Plan - Growth | 4 | 11367.77 | 0.49 | 1.46 | 3.05 | 6.75 | 7.09 |
| Mirae Asset Aggressive Hybrid Fund - Direct Plan - Growth | 3 | 9424.67 | 1.54 | 4.23 | 9.57 | 8.50 | 14.91 |
| Mirae Asset Focused Fund - Direct Plan - Growth | 2 | 7769.11 | 0.84 | 3.73 | 10.04 | 3.73 | 12.63 |
| Mirae Asset Great Consumer Fund - Direct Plan - Growth | NA | 4632.32 | -0.17 | 4.33 | 10.80 | 5.31 | 18.65 |
| Mirae Asset Multicap Fund - Direct Plan - Growth | NA | 4126.15 | 1.25 | 5.16 | 14.24 | 8.23 | 0.00 |
| Mirae Asset Money Market Fund - Direct Plan - Growth | 5 | 3514.10 | 0.51 | 1.50 | 3.52 | 7.75 | 7.56 |